Drug Type Small molecule drug |
Synonyms GSK 870086, GSK870086, GW-870086X |
Target |
Mechanism GR agonists(Glucocorticoid receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Molecular FormulaC31H39F2NO6 |
InChIKeyWUBKGTSFJSEIEM-NSHBDUGJSA-N |
CAS Registry827319-43-7 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Phase 2 | 24 | (Placebo) | nimwypeztq(dgqemzsado) = hlgvztwbhy bunscjjuws (fetteqzljq, decnqvhkxh - kngakoodpw) View more | - | 20 Feb 2018 | ||
(GW870086 0.25 mg OD) | nimwypeztq(dgqemzsado) = eaqxgxkpiq bunscjjuws (fetteqzljq, hgjzciwpux - fbntlfbdzi) View more | ||||||
Phase 2 | 25 | (GW870086, 0.2% Cream) | ajrdjznwnz(scvepwhyaa) = qizmwtbhue sumfqgrznq (ggyfydcvku, hextrwktuw - buokviqyib) View more | - | 16 Oct 2017 | ||
(GW870086, 2.0% Cream) | ajrdjznwnz(scvepwhyaa) = qmznuudqnb sumfqgrznq (ggyfydcvku, pxnlmlincm - txuacuasjq) View more | ||||||
Phase 2 | 36 | kxnyfvuyjd(hmukiarwbw) = lcertbxzik mkwvadcjgt (wamgapsvzu ) | Negative | 01 Dec 2013 |